Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline
Source: SeekingAlpha
2025-11-14 10:28:37 ET
Topline Summary
Read the full article on Seeking Alpha
For further details see:
Autolus Therapeutics: Trading At Cash Is Not Justified With This Pipeline
Autolus Therapeutics plc
NASDAQ: AUTL
AUTL Trading
9.97% G/L:
$1.655 Last:
1,305,129 Volume:
$1.51 Open:
AUTL Latest News
January 12, 2026 07:00:00 am
Autolus Therapeutics Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Net Product Revenue, Pipeline Advancements and Outlook for 2026
AUTL Stock Data
$387,238,481
109,839,996
N/A
49
N/A
Biotechnology & Life Sciences
Healthcare
GB
London
